PATENT CLAIM ANALYSIS

Application Number: 15890006
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "255030"]

Abstract:
A dose regimes comprising the simultaneous administration of two pharmaceutical compositions, wherein the first pharmaceutical composition is a composition comprising vortioxetine or a pharmaceutically acceptable salt thereof for once daily oral administration, and the second pharmaceutical composition is a composition comprising vortioxetine or a pharmaceutically acceptable salt thereof which together with said first composition quickly achieves a steady-state plasma level of vortioxetine in said patient which steady-state plasma level is the same as the steady-state vortioxetine plasma level achieved by the administration to said patient of said first composition alone.

Claim (Index 6):
A kit, comprising:\n an oral pharmaceutical composition comprising 5 mg-20 mg vortioxetine or a pharmaceutical acceptable salt thereof for once daily oral administration; and a second pharmaceutical composition for nasal administration comprising 7 mg-57 mg vortioxetine or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.97872
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15703572', '15636238', '15152902', '14649087', '13443698']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7628285318965975
- 35 USC 102 Novelty (BERT): 0.5852608120188916
- Combined Prediction Score: 0.7450717599088269
- Mean Citation Score: 351.653764
- Max Citation Score: 475.3318
- Similarity Product: 464.01430603508936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test